
Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2550
2026-05-11 15:35:42With a remarkable surge to Rs 2550 on 11 May 2026, Fredun Pharmaceuticals Ltd has reached a new 52-week and all-time high, marking a spectacular 264.41% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained earnings growth, setting the stage for a compelling price rally despite broader market headwinds.
Read More
Strong Momentum Meets Stretched Valuations as Fredun Pharmaceuticals Ltd Reaches All-Time High
2026-05-11 15:22:08After a volatile session marked by an intraday swing of over 8%, Fredun Pharmaceuticals Ltd closed at a fresh all-time high of Rs 2,530 on 11 May 2026, extending its recent rally and outperforming the broader sector by nearly 4%. This milestone caps a remarkable run that has seen the stock surge over 265% in the past year, vastly outpacing the Sensex’s modest decline.
Read MoreFredun Pharmaceuticals Declines 2.10% Despite Multiple All-Time Highs: 5 Key Factors Behind the Week’s Volatility
2026-05-09 13:09:11Key Events This Week 4 May: New 52-week and all-time high at Rs.2,424 5 May: Further 52-week and all-time high at Rs.2,471 6 May: New 52-week and all-time high at Rs.2,548 8 May: Week closes at Rs.2,374.95 (-2.10%) Week OpenRs.2,426.00 Week CloseRs.2,374.95<div class="stat-change negative...
Read More
Fredun Pharmaceuticals Ltd is Rated Buy
2026-05-06 10:11:00Fredun Pharmaceuticals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 13 Apr 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 May 2026, providing investors with the latest insights into its performance and outlook.
Read More
Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2548
2026-05-06 09:48:44Surging to a new all-time high of Rs 2,548 on 6 May 2026, Fredun Pharmaceuticals Ltd has demonstrated remarkable price momentum, extending gains over four consecutive sessions to deliver a near 20% rally. This milestone caps a spectacular 257.45% return over the past year, vastly outperforming the Sensex’s decline of 4.16% during the same period.
Read More
Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2471
2026-05-05 09:47:32Surging past its previous peaks, Fredun Pharmaceuticals Ltd has reached a new 52-week high of Rs 2471 on 05 May 2026, marking a remarkable rally of 242.02% over the past year. This milestone is underpinned by a confluence of strong technical indicators and sustained price momentum, even as the broader market trades cautiously.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
12-Jun-2026 | Source : BSETranscript of the Earnings conference call held on 10th June 2026 for Q4 FY26.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
10-Jun-2026 | Source : BSEAudio Recording of the Q4 and year ended for the FY26 Earnings Conference Call
Announcement under Regulation 30 (LODR)-Newspaper Publication
09-Jun-2026 | Source : BSENewspaper Clipping- Information regarding 39th Annual General Meeting to be held on 30th June 2026 through video conference/other audio visual means.
Corporate Actions
No Upcoming Board Meetings
Fredun Pharmaceuticals Ltd has declared 7% dividend, ex-date: 23 Jun 26
No Splits history available
No Bonus history available
No Rights history available


